Filing Details

Accession Number:
0001193805-20-001004
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-12 08:02:18
Reporting Period:
2020-08-11
Accepted Time:
2020-08-12 08:02:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368514 Adma Biologics Inc. ADMA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283260 Brian Lenz C/O Adma Biologics, Inc.
465 State Route 17
Ramsey NJ 07446
Evp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-11 4,000 $2.97 76,142 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 40,000 RSUs granted on February 28, 2020, which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting.